IGF-1 LR3 is a recombinant analogue of human IGF-1 incorporating an arginine substitution at position 3 and an N-terminal 13-amino acid extension
CJC-1295 (No DAC), also called Modified GRF(1-29), is a short-acting lab-made analog of growth-hormone-releasing hormone
Do not take more than 150mcg of IGF-1 LR3 per day for four weeks, as high doses of IGF-1 have been shown to cause some pretty extreme hypoglycemia and blood sugar dysregulation
By boosting growth hormone production naturally, these peptides address the root causes of midlife changes like stubborn belly fat, sluggish recovery, and dwindling energy
Furthermore, while keeping safety and comfort in mind, choosing the correct technique produces the greatest outcomes
DES IGF-1 is sometimes preferred in research where rapid clearance is actually useful, such as studies of acute receptor activation followed by washout